IDXX · Idexx Laboratories Inc /De
$544.32
+4.96 (+0.92%)
At close · Jul 24
Market Cap
$42.94B
Shares
78.88M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$4.3B
+10.4%
FY2025
Net Income
$1.06B
+19.3%
FY2025
Gross Margin
61.8%
+0.8pp
FY2025
Operating Margin
31.6%
+2.6pp
FY2025
Diluted EPS
$13.08
+22.6%
FY2025
Operating Cash Flow
$1.18B
+27.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $4.68B – $4.76B | $4.45B | $4.3BG | $3.9B | $3.66B | $3.37B | $3.22B | $2.71B | $2.41B | $2.21B | $1.97B | $1.78B | $1.6B | $1.49B | $1.38B | $1.29B | $1.22B | $1.1B | $1.03B | $1.02B | |
| — | $16.3M | $15.8M | $13.9M | $20.7M | $20.3M | $20.8M | $17.5M | $20.8M | $12.2M | — | — | — | — | — | — | — | — | — | — | |
| — | $1.69B | $1.64B | $1.52B | $1.47B | $1.36B | $1.33B | $1.14B | $1.04B | $971.7M | $871.68M | $799.99M | $711.62M | $669.69M | $620.94M | $594.19M | $572.18M | $524.77M | $505.35M | $494.26M | |
| — | $2.76B | $2.66B | $2.38B | $2.19B | $2B | $1.89B | $1.57B | $1.37B | $1.24B | $1.1B | $975.44M | $890.27M | $816.12M | $756.12M | $699.15M | $646.51M | $578.62M | $526.28M | $529.77M | |
| — | — | 61.8% | 61.04% | 59.82% | 59.52% | 58.76% | 58.04% | 56.73% | 56.1% | 55.73% | 54.94% | 55.58% | 54.93% | 54.91% | 54.06% | 53.05% | 52.44% | 51.01% | 51.73% | |
| — | $257.93M | $251.21M | $219.79M | $190.95M | $254.82M | $161.01M | $141.25M | $133.19M | $117.86M | $109.18M | $101.12M | $99.68M | $98.26M | $88M | $82.01M | $76.04M | $68.6M | $65.12M | $70.67M | |
| — | $662.57M | $643.55M | $588.51M | $566.07M | $524.51M | $486.74M | $434.44M | $418.19M | $387.41M | $354.29M | $317.06M | $299.96M | $283.71M | $243.49M | $216.96M | $204.85M | $179.63M | $167.75M | $169.96M | |
| — | $432.35M | $404.79M | $442.29M | $335.83M | $326.25M | $309.66M | $300.83M | $261.32M | $244.94M | $220.88M | $207.02M | $182.51M | $173.89M | $157.86M | $137.61M | $129.39M | $126.52M | $117.44M | $116.68M | |
| — | — | $20.2M | $17.1M | $13.8M | $15M | $12.1M | $9.8M | $9.4M | $8.9M | $9M | $9.5M | $10.4M | $9.8M | $9.7M | $9.8M | $8.7M | $9M | — | — | |
| — | — | $145.18M | $129.94M | $114.91M | $111.9M | $104.6M | $96M | $88.01M | $83.18M | $83.14M | $78.22M | $68.96M | $58.89M | $54.6M | $52.41M | $48.2M | $45.96M | $49.77M | $47.98M | |
| — | $1.35B | $1.3B | $1.25B | $1.09B | $1.11B | — | — | — | $750.21M | — | — | — | — | — | — | — | — | — | — | |
| — | $1.41B | $1.36B | $1.13B | $1.1B | $898.77M | $932.03M | $694.52M | $552.85M | $491.34M | $413.03M | $350.24M | $299.91M | $260.26M | $266.76M | $262.56M | $236.23M | $203.88M | $175.97M | $172.46M | |
| — | — | 31.6% | 28.95% | 29.97% | 26.69% | 28.99% | 25.66% | 22.97% | 22.2% | 20.98% | 19.73% | 18.72% | 17.52% | 19.37% | 20.3% | 19.38% | 18.48% | 17.06% | 16.84% | |
| — | — | $1.51B | $1.26B | $1.21B | $1.01B | $1.04B | $790.52M | $640.86M | $574.51M | $496.17M | $428.46M | $368.87M | $319.14M | $321.36M | $314.97M | $284.43M | $249.84M | $225.74M | $220.44M | |
| — | $38.93M | $38.85M | $31.21M | $41.58M | $39.86M | $29.81M | $33.13M | $31.06M | $34.74M | $37.23M | $32.05M | $29.24M | $15.43M | $5.39M | $3.85M | $3.55M | $2.42M | $1.92M | $4.59M | |
| — | $1.37B | $1.32B | $1.11B | $1.06B | $859.97M | $902.65M | $661.99M | $522.22M | $457.74M | $381.06M | $321.85M | $273.14M | $246.56M | $263.26M | $260.62M | $234.42M | $202.13M | $174.54M | $170.19M | |
| — | $274.31M | $264.73M | $221.96M | $216.13M | $180.88M | $157.81M | $79.85M | $94.43M | $80.7M | $117.79M | $99.79M | $81.01M | $64.6M | $75.47M | $82.33M | $72.67M | $60.81M | $52.3M | $54.02M | |
| — | $1.1B | $1.06B | $887.87M | $845.04M | $679.09M | $744.85M | $581.78M | $427.72M | $377.03M | $263.14M | $222.05M | $192.08M | $181.91M | $187.8M | $178.27M | $161.79M | $141.28M | $122.23M | $116.17M | |
| — | — | 24.62% | 22.78% | 23.08% | 20.17% | 23.17% | 21.49% | 17.77% | 17.04% | 13.36% | 12.51% | 11.99% | 12.24% | 13.64% | 13.78% | 13.28% | 12.8% | 11.85% | 11.34% | |
| — | — | — | — | $0 | $0 | -$1000 | $355K | $72K | $16K | $125K | $9000 | $57K | $45K | -$6000 | $20K | -$32K | $36K | $10K | — | |
| — | $1.12B | $1.08B | $865.43M | $851.63M | $654.78M | $744.98M | $574.34M | $423.33M | $371.71M | $269.73M | $221.26M | $157.88M | $160.21M | $185.47M | $178.78M | $163.76M | $144.41M | — | — | |
| USD/shares | — | — | $13.17 | $10.77 | $10.17 | $8.12 | $8.74 | $6.82 | $4.97 | $4.34 | $3.00 | $2.47 | $2.07 | $1.82 | $1.77 | $3.24 | $2.85 | $2.45 | $2.08 | $1.94 |
| USD/shares | $14.45 – $14.90 | — | $13.08G | $10.67 | $10.06 | $8.03 | $8.60 | $6.71 | $4.89 | $4.26 | $2.94 | $2.44 | $2.05 | $1.79 | $1.74 | $3.17 | $2.78 | $2.37 | $2.01 | $1.87 |
| shares | — | — | 80.43M | 82.47M | 83.07M | 83.62M | 85.2M | 85.34M | 86.12M | 86.86M | 87.77M | 89.73M | 92.6M | 100.09M | 106.32M | 54.99M | 56.79M | 57.71M | 58.81M | 59.95M |
| shares | — | — | 81.03M | 83.25M | 83.98M | 84.6M | 86.57M | 86.72M | 87.54M | 88.47M | 89.57M | 90.88M | 93.65M | 101.5M | 107.97M | 56.16M | 58.21M | 59.56M | 60.68M | 62.25M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $7.27B in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
9.71×
Diagnostics & Research median 2.76×
EV/EBIT
30.71×
Diagnostics & Research median 30.71×
P/E (TTM)
40.05×
Diagnostics & Research median 32.60×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Companion Animal Group Segment | $3,953,285,000 | $3,574,044,000 | $3,352,356,000 | $3,058,793,000 | $2,889,960,000 | $2,385,765,000 | $2,119,183,000 | — |
| Water Segment | $201,149,000 | $185,112,000 | $168,149,000 | $155,720,000 | $146,505,000 | $128,625,000 | $132,850,000 | $125,198,000 |
| Livestock and Poultry Diagnostics Segment | $131,787,000 | $122,060,000 | $121,659,000 | $122,607,000 | $135,887,000 | $145,845,000 | $132,635,000 | — |
| CAG Segment | — | — | — | — | — | — | — | $1,935,428,000 |
| LPD Segment | — | — | — | — | — | — | — | $130,581,000 |
| Other Segment | — | — | $18,789,000 | $30,204,000 | $43,008,000 | $46,420,000 | $22,240,000 | $22,035,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $2,752,785,000 | $2,533,174,000 | $2,391,427,000 | $2,182,959,000 | $1,995,683,000 | $1,691,224,000 | $1,495,516,000 | $1,357,909,000 |
| Europe the Middle East and Africa Other | $230,031,000 | $196,313,000 | $176,396,000 | $161,577,000 | $167,525,000 | $148,049,000 | $122,206,000 | $114,877,000 |
| Germany | $206,759,000 | $173,682,000 | $149,789,000 | $137,876,000 | $146,762,000 | $119,353,000 | $104,081,000 | $100,459,000 |
| Canada | $167,325,000 | $152,885,000 | $150,110,000 | $142,743,000 | $139,727,000 | $107,398,000 | $99,550,000 | $94,206,000 |
| United Kingdom | $154,435,000 | $134,630,000 | $121,745,000 | $110,400,000 | $114,955,000 | $90,156,000 | $90,969,000 | $87,807,000 |
| France | $126,003,000 | $110,795,000 | $96,797,000 | $84,479,000 | $90,836,000 | $74,814,000 | $64,767,000 | $60,319,000 |
| Asia Pacific Other | $124,364,000 | $110,104,000 | $104,107,000 | $96,291,000 | — | — | — | — |
| Australia | $112,247,000 | $101,959,000 | $95,465,000 | $96,408,000 | $94,414,000 | $79,629,000 | $71,069,000 | $63,386,000 |
| Latin America and Caribbean | $90,411,000 | $83,690,000 | $83,923,000 | $75,035,000 | $66,623,000 | $51,863,000 | $56,515,000 | — |
| Japan | $83,362,000 | $73,139,000 | $75,569,000 | $77,661,000 | $84,275,000 | $74,725,000 | $67,246,000 | $60,213,000 |
| Spain | $70,971,000 | $61,857,000 | $52,332,000 | $46,982,000 | $48,169,000 | $39,265,000 | $36,439,000 | $33,687,000 |
| Italy | $66,857,000 | $58,224,000 | $53,787,000 | $48,192,000 | $52,062,000 | $42,817,000 | $39,725,000 | $36,956,000 |
| Switzerland | $41,696,000 | $37,183,000 | $34,830,000 | $30,646,000 | $31,984,000 | $24,850,000 | $20,855,000 | $19,875,000 |
| Netherlands | $40,500,000 | $34,047,000 | $30,508,000 | $26,882,000 | $29,656,000 | $23,461,000 | $19,397,000 | $18,090,000 |
| China | $35,956,000 | $35,822,000 | $44,168,000 | $49,193,000 | $63,166,000 | $70,845,000 | $57,518,000 | $57,621,000 |
| Asia Pacific Region Other | — | — | $104,107,000 | $96,291,000 | $89,523,000 | $68,206,000 | $61,055,000 | $56,868,000 |
| Americas | — | — | $2,625,460,000 | $2,400,737,000 | — | $1,850,485,000 | $1,651,581,000 | — |
| Asia Pacific | — | — | $319,309,000 | $319,553,000 | — | $293,405,000 | $256,888,000 | — |
| Latin America | — | — | — | — | — | $51,863,000 | $56,515,000 | $50,969,000 |
| EMEA | — | — | $716,184,000 | $647,034,000 | — | $562,765,000 | $498,439,000 | — |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Product | $2,539,210,000 | $2,248,178,000 | $2,089,936,000 | $1,928,773,000 | $1,875,308,000 | $1,586,809,000 | $1,423,144,000 | $1,322,683,000 |
| Service | $1,764,492,000 | $1,649,326,000 | $1,571,017,000 | $1,438,551,000 | $1,340,052,000 | $1,119,846,000 | $983,764,000 | $890,559,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|
| Companion Animal Group Segment | $1,012,740,000 | $800,949,000 | $824,022,000 | $574,887,000 | $462,605,000 | — | — |
| Water Segment | $74,340,000 | $72,519,000 | $65,444,000 | $58,867,000 | $61,923,000 | $56,639,000 | $50,616,000 |
| Livestock and Poultry Diagnostics Segment | $9,975,000 | $19,809,000 | $28,636,000 | $40,008,000 | $24,735,000 | — | — |
| Other Segment | $73,000 | $5,488,000 | $13,926,000 | $20,762,000 | $3,583,000 | $2,619,000 | $4,837,000 |
| CAG Segment | — | — | — | — | — | $412,623,000 | $363,557,000 |
| LPD Segment | — | — | — | — | — | $19,454,000 | $16,464,000 |
Operating Margin by Segment (%)
| Component | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Companion Animal Group Segment | 30.2% | 26.2% | 28.5% | 24.1% | 21.8% | — |
| Water Segment | 44.2% | 46.6% | 44.7% | 45.8% | 46.6% | 45.2% |
| Livestock and Poultry Diagnostics Segment | 8.2% | 16.2% | 21.1% | 27.4% | 18.6% | — |
| CAG Segment | — | — | — | — | — | 21.3% |
| LPD Segment | — | — | — | — | — | 14.9% |
| Other Segment | 0.4% | 18.2% | 32.4% | 44.7% | 16.1% | 11.9% |
Key facts
CIK
874716
CUSIP
45168D104
13F (30d)
337 filings
330 filers
Visit website
Investor relations